Literature DB >> 25560598

A contemporary and critical appraisal of 'indeterminate colitis'.

Robert D Odze1.   

Abstract

Distinguishing ulcerative colitis (UC) from Crohn's disease (CD) is normally based on evaluation of a variety of clinical, radiologic, serologic and pathologic findings, the latter in biopsy and/or resection specimens. Unfortunately, some patients with IBD show overlapping pathologic features of UC and CD, which makes definite distinction between these two disorders difficult or even impossible. In most instances of uncertainty, the patient shows clinical and pathologic features of UC, but in addition, the patient's colon resection specimen reveals one or more CD-like features. In this setting, a diagnosis of indeterminate colitis (IC) is often rendered. IC is not a distinct disease entity, and, thus, it has no diagnostic criteria. The most common causes of uncertainty in IBD pathology that may lead to a diagnosis of IC in a colon resection specimen includes the presence of fulminant (severe and toxic) colitis, insufficient radiologic, endoscopic, or pathologic information (including analysis of prior biopsies) on the patient, failure to utilize major diagnostic criteria as hard evidence in favor of CD, failure to recognize unusual variants of UC and CD that may mimic each other, failure to recognize non-IBD mimics and other superimposed diseases that cause unusual pathologic features in a resection specimen, an attempt to distinguish UC from CD in mucosal biopsies of the colon and ileum, or an attempt to change the patients diagnosis (of UC or CD) based on pouch or diversion-related complications. Details of each of these causes of uncertainty are discussed, in detail, in this review article. A diagnosis of IC should never be made clinically or by pathologists based on evaluation of pre-resection colonic mucosal biopsies. Ultimately, the majority of indeterminate cases represent UC, and, thus, most of these patient can be treated safely with a colectomy combined with an ileal pouch anal anastomosis procedure.

Entities:  

Mesh:

Year:  2015        PMID: 25560598     DOI: 10.1038/modpathol.2014.131

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

Review 1.  Diagnostic dilemmas in chronic inflammatory bowel disease.

Authors:  Maurice B Loughrey; Neil A Shepherd
Journal:  Virchows Arch       Date:  2017-11-04       Impact factor: 4.064

2.  Can indeterminate colitis cause colonic cancer in non-colitic colon? A case report.

Authors:  R K Mehmood; S Ahmed; E Jehangir
Journal:  Int J Colorectal Dis       Date:  2015-03-06       Impact factor: 2.571

Review 3.  Is There a Role for Ileal Pouch Anal Anastomosis in Crohn's Disease?

Authors:  Nicole E Lopez; Karen Zaghyian; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

4.  Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified.

Authors:  Sara Monteiro; Francisca Dias de Castro; Pedro Boal Carvalho; Bruno Rosa; Maria João Moreira; Rolando Pinho; Miguel Mascarenhas Saraiva; José Cotter
Journal:  World J Gastrointest Endosc       Date:  2017-01-16

5.  Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Authors:  Amanda D Williams; Olga Y Korolkova; Amos M Sakwe; Timothy M Geiger; Samuel D James; Roberta L Muldoon; Alan J Herline; J Shawn Goodwin; Michael G Izban; Mary K Washington; Duane T Smoot; Billy R Ballard; Maria Gazouli; Amosy E M'Koma
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

Review 6.  Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review.

Authors:  Consolato Sergi; Vincenzo Villanacci; Antonio Carroccio
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

7.  The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database.

Authors:  Karoline Freeman; Ronan Ryan; Nicholas Parsons; Sian Taylor-Phillips; Brian H Willis; Aileen Clarke
Journal:  BMC Gastroenterol       Date:  2021-03-26       Impact factor: 3.067

Review 8.  Microbiome, Metabolome and Inflammatory Bowel Disease.

Authors:  Ishfaq Ahmed; Badal C Roy; Salman A Khan; Seth Septer; Shahid Umar
Journal:  Microorganisms       Date:  2016-06-15

9.  Neonatal Presentation of Unremitting Inflammatory Bowel Disease.

Authors:  Sara Ebrahimi; Gholamreza Khademi; Seyed Ali Jafari; Nona Zaboli Nejad; Abdolreza Norouzy; Bahareh Imani
Journal:  Iran J Med Sci       Date:  2018-05

10.  Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the IMRD-UK data.

Authors:  Karoline Freeman; Sian Taylor-Phillips; Brian H Willis; Ronan Ryan; Aileen Clarke
Journal:  BMJ Open       Date:  2021-02-22       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.